360 One Wam Regulatory Approval

Other Announcement

360 One Wam Other Announcement

360 ONE WAM sold 1,200 equity shares worth Rs.12,26,292 on NSE on 23 October 2026 under a PIT disclosure. The seller is a Designated Person, and the holding fell to zero.

Value

₹0.12 Cr

Employee Stock Options

360 One Wam Employee Stock Options

360 ONE WAM LIMITED allotted 4,61,384 equity shares to employees following the exercise of stock options under its ESOP scheme.

Debt & Borrowing

360 One Wam Debt & Borrowing: ₹200 Cr

360 ONE WAM redeemed its ₹200 Crore Commercial Paper in full at maturity on 22 October 2026. The entire principal was repaid to investors.

Value

₹200.0 Cr

Convertible Warrants

360 One Wam Convertible Warrants

UBS AG warrants converted into 2.05 crore equity shares at Rs.1,030 each. Balance 75% exercise price of Rs.1,583.85 Crore received by 360 ONE WAM.

Value

₹1,584 Cr

Convertible Warrants

360 One Wam Convertible Warrants

360 ONE WAM allotted 2,05,02,939 shares to UBS AG on warrant conversion at Rs.1,030 each. Consideration: Rs.2,111.80 Crore, giving UBS ~4.8%.

Value

₹2,112 Cr

Earnings Call

360 One Wam Earnings Call Transcript: Key Takeaways

Q2 FY27 earnings call highlights solid AUM growth to ₹9 lakh Cr (up 31% YoY). PAT stood at ₹302 Cr.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.